Page 15 - Clinical Strategy 2024-2029

CLINICAL STRATEGY 2024-2029
Theme 4:
Research and
Innovation
We work continually to lead advancements
in clinical care, and its delivery, through
impactful clinical research and an
openness and drive to harness
technological innovations for the benefit
of our patients, clients, the profession and
animal welfare
To achieve this aim we will:
 Strengthen our internal culture, backed up
by effective systems and processes, that
positively and consciously enables our
clinical teams to undertake clinical
research and recognises the specifi c
challenges of performing research in a
clinical environment
 Engage with the establishment of the RVC
Research Institute, with the aim of creating
an environment that fosters collaboration
between our clinical units and with our
colleagues in the biological sciences
to encourage inter-disciplinary and welfare and patient care
cross-departmental approaches
 Focus our clinical research on areas  Develop a structure to horizon scan and
review innovations in health care, and
of greatest impact for animal welfare, a process to prioritise our investment in
balancing research relevant to general equipment and our team, to ensure we
practice with world-leading clinical remain at the cutting-edge of patient
innovation that recognises the value of care
our unique referral caseload and ensures
the opportunities to learn from our
patients for the future is optimised
 Explore opportunities for research
funding, including collaborations with
industry partners, leveraging our unique
organisational position that combines
world-leading clinical expertise with
strength in the biological sciences and
recognising the potential this brings for
translational research and One Health
 Develop our expertise and reputation in
machine learning, predictive analytics
and health tech and become the
preferred institution for veterinary input
to these emerging technologies, and
provide an independent voice in the
evaluation of their value for animal
15
15